Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Gastrointestinal Manifestations in Patients With Coronavirus Disease-2019 (Covid-19): Impact on Clinical Outcomes Publisher



Tabesh E1 ; Soheilipour M1 ; Sami R2 ; Mansourian M3 ; Tabesh F4 ; Soltaninejad F5 ; Dehghan M6 ; Nikgoftar N6 ; Gharavinia A6 ; Ghasemi K7 ; Adibi P8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Gastroenterology And Hepatology Research Center, Isfahan University Of Medical Sciences, Isfahan, Iran
  2. 2. Department Of Pulmonology, School Of Medicine, Isfahan University Of Medical Sciences, Isfahan, Iran
  3. 3. Department Of Biostatistics And Epidemiology, School Of Health, Isfahan University Of Medical Sciences, Isfahan, Iran
  4. 4. Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University Of Medical Sciences, Isfahan, Iran
  5. 5. Bamdad Respiratory And Sleep Research Center, Isfahan University Of Medical Sciences, Isfahan, Iran
  6. 6. General Physician, Department Of Family And Emergency Medicine, Faculty Of Medicine, Azad University Of Medical Science, Isfahan, Iran
  7. 7. Department Of Biostatistics & Epidemiology, School Of Health, Isfahan University Of Medical Sciences, Isfahan, Iran
  8. 8. Integrative Functional Gastroenterology Research Center, Isfahan University Of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2022


Abstract

Background: In this study, we summarized the data on gastrointestinal (GI) involvement and the potential association with clinical outcomes among the patients admitted to Khorshid Hospital. Materials and Methods: We investigated 1113 inpatients (≥18 years old) diagnosed with coronavirus disease-2019 (COVID-19) from March to June 2020 in Khorshid Hospital. We collected demographic details, clinical information, vital signs, laboratory data, treatment type, and clinical outcomes from patients' medical records. The data of patients with GI symptoms were compared with those without GI symptoms. Results: A total of 1113 patients were recruited (male = 648). GI symptoms were observed in 612 (56.8%) patients (male = 329), the most common of which were nausea 387 (34.7%), followed by diarrhea 286 (25.7%), vomiting 260 (23.4%), and abdominal pain 168 (15.0%). The most prominent non-GI symptoms were cough 796 (71.5%), fever 792 (71.2%), shortness of breath 653 (58.7%), and body pain 591 (53.1%). The number of patients who were discharged, died, and were admitted to intensive care unit was significantly different in groups on the basis of GI and non-GI symptoms (P = 0.002, 0.009, 0.003). Conclusion: While COVID-19 was predominantly diagnosed in males, GI symptoms were more commonly reported by females. The results indicated that GI symptoms in COVID-19 patients are common, and the symptoms are not correlated with the severity of the disease. Moreover, the presence of GI symptoms was positively related to milder disease. Among COVID-19 positive patients, the clinical outcomes of the GI group were promising, compared to those of non-GI group. © 2022 Journal of Education and Health Promotion Published by Wolters Kluwer - Medknow.
Other Related Docs
18. Iranian Pediatric Covid-19 Epidemiology and Clinical Characteristics, Canadian Journal of Infectious Diseases and Medical Microbiology (2021)
31. Isfahan Covid Cohort Study: Rationale, Methodology, and Initial Results, Journal of Research in Medical Sciences (2022)
40. Coronavirus Disease-19 (Covid-19) Presenting With Severe Acute Pancreatitis: A Case Report From Iran, Journal of Advances in Medical and Biomedical Research (2022)
41. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
45. Abdominal Signs and Symptoms of Covid-19 in Children, Archives of Pediatric Infectious Diseases (2021)
49. Covid-19 and Acute Pancreatitis: A Case Report, Acta Medica Iranica (2021)